Simulation framework for generating intratumor heterogeneity patterns in a cancer cell population

被引:13
|
作者
Iwasaki, Watal M. [1 ]
Innan, Hideki [1 ]
机构
[1] Grad Univ Adv Studies, SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama 2400193, Japan
来源
PLOS ONE | 2017年 / 12卷 / 09期
基金
日本学术振兴会;
关键词
TUMOR EVOLUTION; MODEL; GROWTH; MICROENVIRONMENT; MORPHOLOGY; INFERENCE; GENOMICS; INVASION; DRIVEN;
D O I
10.1371/journal.pone.0184229
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
As cancer cell populations evolve, they accumulate a number of somatic mutations, resulting in heterogeneous subclones in the final tumor. Understanding the mechanisms that produce intratumor heterogeneity is important for selecting the best treatment. Although some studies have involved intratumor heterogeneity simulations, their model settings differed substantially. Thus, only limited conditions were explored in each. Herein, we developed a general framework for simulating intratumor heterogeneity patterns and a simulator (tumopp). Tumopp offers many setting options so that simulations can be carried out under various settings. Setting options include how the cell division rate is determined, how daughter cells are placed, and how driver mutations are treated. Furthermore, to account for the cell cycle, we introduced a gamma function for the waiting time involved in cell division. Tumopp also allows simulations in a hexagonal lattice, in addition to a regular lattice that has been used in previous simulation studies. A hexagonal lattice produces a more biologically reasonable space than a regular lattice. Using tumopp, we investigated how model settings affect the growth curve and intratumor heterogeneity pattern. It was found that, even under neutrality (with no driver mutations), tumopp produced dramatically variable patterns of intratumor heterogeneity and tumor morphology, from tumors in which cells with different genetic background are well intermixed to irregular shapes of tumors with a cluster of closely related cells. This result suggests a caveat in analyzing intratumor heterogeneity with simulations with limited settings, and tumopp will be useful to explore intratumor heterogeneity patterns in various conditions.
引用
收藏
页数:28
相关论文
共 50 条
  • [1] Signaling, cancer cell plasticity, and intratumor heterogeneity
    Cordani, Marco
    Dando, Ilaria
    Ambrosini, Giulia
    Gonzalez-Menendez, Pedro
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [2] Intratumor heterogeneity in epigenetic patterns
    Assenov, Yassen
    Brocks, David
    Gerhaeuser, Clarissa
    SEMINARS IN CANCER BIOLOGY, 2018, 51 : 12 - 21
  • [3] Intratumor heterogeneity in prostate cancer
    Yadav, Shalini S.
    Stockert, Jennifer A.
    Hackert, Victoria
    Yadav, Kamlesh K.
    Tewari, Ashutosh K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 349 - 360
  • [4] Intratumor Heterogeneity and Cancer Promotion
    Arima, Yoshimi
    CANCER SCIENCE, 2018, 109 : 427 - 427
  • [5] Intratumor Heterogeneity in Breast Cancer
    Beca, Francisco
    Polyak, Kornelia
    NOVEL BIOMARKERS IN THE CONTINUUM OF BREAST CANCER, 2016, 882 : 169 - 189
  • [6] Modeling intratumor heterogeneity in breast cancer
    Mcdonough, Elizabeth
    Barroso, Margarida
    Ginty, Fiona
    Corr, David T.
    BIOFABRICATION, 2025, 17 (01)
  • [7] Intratumor heterogeneity in thyroid cancer progression
    Pantina, Vincenzo Davide
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Metabolic intratumor heterogeneity of breast cancer
    Giskeodegard, Guro Fannelob
    Badia, Marina Perea
    Bofin, Anna
    Madssen, Torfinn Stove
    Lundgren, Steinar
    Fjosne, Hans
    Bathen, Tone Frost
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Single Cell Profiling of Intratumor and Circulating Tumor Cell Heterogeneity for Better Cancer Prognostication
    Bin, Lim Su
    CANCER SCIENCE, 2022, 113
  • [10] Intratumor heterogeneity of non-small-cell lung cancer with EGFR mutations
    Qiao, Sitan
    Zhao, Xin
    Zhou, Xinlan
    Zhang, Yaxiong
    Zhang, Li
    Wu, Kui
    CANCER RESEARCH, 2019, 79 (13)